Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

CorVel (NASDAQ:CRVL) said revenue and earnings increased in its March quarter and fiscal 2026, as growth in its Network Solutions business, stronger bookings and operating efficiency helped offset a higher effective tax rate. President and Chief Executive Officer Michael Combs opened the call by sa

MarketBeat

INM Stock Alert: What to Know as InMed, Mentari Announce Merger

InMed stock rallied yesterday on a merger announcement with Mentari Therapeutics. Here’s why the transaction is concerning for INM investors.

Barchart

Stocks Rally as Crude Oil and Bond Yields Slump

The S&P 500 Index ($SPX ) (SPY ) today is up +0.78%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.24%. June E-mini S&P futures (ESM26 ) are up +0.70%, and June E-mini Nasdaq futures...

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Analog Devices Q2 Earnings Call Highlights

Analog Devices (NASDAQ:ADI) reported record fiscal second-quarter 2026 results, with revenue, profitability and earnings per share exceeding the high end of the company’s prior guidance, executives said on the company’s earnings call. Chief Executive Officer and Chair Vincent Roche said the quarter

MarketBeat

BC-Most Active Stocks

NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks.

AAP

Stocks Climb on Lower Bond Yields and Chipmaker Strength

The S&P 500 Index ($SPX ) (SPY ) today is up +0.27%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.09%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.55%. June E-mini S&P futures (ESM26 ) are up +0.26%, and June E-mini Nasdaq futures...

Barchart

Roivant Sciences Q4 Earnings Call Highlights

Roivant Sciences (NASDAQ:ROIV) executives used the company’s fourth-quarter earnings call to highlight new open-label data for IMVT-1402 in difficult-to-treat rheumatoid arthritis, upcoming pulmonary hypertension data for mosliciguat and continued preparation for a potential brepocitinib launch in d

MarketBeat

Read news from The Economist, FT, and more,
with one subscription

EuroDry Q1 Earnings Call Highlights

EuroDry (NASDAQ:EDRY) reported a return to profitability in the first quarter of 2026, supported by stronger charter rates despite operating a smaller average fleet than a year earlier, while management said it is expanding its newbuilding program with two additional Kamsarmax bulk carriers. Chairm

MarketBeat

KANZHUN Q1 Earnings Call Highlights

KANZHUN (NASDAQ:BZ) reported higher first-quarter revenue and profit as the operator of the BOSS Zhipin recruitment platform said user growth remained strong despite a later Chinese New Year that shifted more of the peak hiring season into March and April. Founder, Chairman and CEO Peng Zhao said t

MarketBeat

GDS Q1 Earnings Call Highlights

GDS (NASDAQ:GDS) said demand for data center capacity in China is accelerating as artificial intelligence workloads drive larger deployments, prompting the company to prepare for a new investment cycle backed by a significantly expanded land bank and strong liquidity. On the company’s first-quarter

MarketBeat

Block’s Pivot to Profits and AI Is Turning Heads

Block stock is gaining attention after strong earnings, rising profitability, AI initiatives, and higher guidance despite regulatory and valuation concerns.

MarketBeat

AI boom: Global stock market order shuffles as Taiwan, South Korea overtake Western giants

Asian markets are making waves. South Korea's Kospi and Taiwan's stock market have surged, driven by the AI boom. These markets are now outperforming many Western exchanges. Investors are watching closely as capital shifts towards these AI-focused economies. This new global stock market order presents exciting opportunities and potential risks.

The Economic Times

Blackbaud CEO Touts AI Fundraising Agents, Rule of 45 Path at JPMorgan Conference

Blackbaud (NASDAQ:BLKB) Chief Executive Officer Mike Gianoni outlined the company’s market position, artificial intelligence strategy and financial priorities during a discussion with Zach Canter, managing director in JPMorgan’s technology investment banking group. Gianoni described Blackbaud as a

MarketBeat

Aura Biosciences Highlights Bel-Sar Eye Cancer Strategy, Mid-Year Bladder Data

Aura Biosciences (NASDAQ:AURA) executives outlined the company’s strategy for its lead candidate bel-sar during a session at the H.C. Wainwright Connect Conference, emphasizing ocular oncology as the company’s initial development focus while also discussing ongoing work in non-muscle invasive bladde

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

The Economic Times

US stock market on Wednesday: S&P 500, Dow Jones, Nasdaq to fall again today? These factors offer hints

US Stock Market today: Dow Jones, S&P 500, Nasdaq investors are looking for positive turnaround in the Wall Street.

MarketBeat

Red Robin Gourmet Burgers Q1 Earnings Call Highlights

Red Robin Gourmet Burgers (NASDAQ:RRGB) reported continued operating improvement in its fiscal first quarter of 2026, with management pointing to better traffic trends, higher restaurant-level margins and early traction from its value-focused menu strategy. President and Chief Executive Officer Dav

MarketBeat

8X8 Q4 Earnings Call Highlights

8X8 (NASDAQ:EGHT) reported its fourth consecutive quarter of year-over-year revenue growth in fiscal fourth quarter 2026, with executives saying the company is seeing momentum from usage-based communications, artificial intelligence tools and disciplined cost management. Chief Executive Officer Sam

MarketBeat

Adagene Spotlights ADG126 Strategy as Masked CTLA-4 Trial Advances in Colorectal Cancer

Adagene (NASDAQ:ADAG) Chief Strategy Officer Mickael Chane-Du outlined the company’s clinical strategy for its lead antibody program, ADG126, during a discussion with Stifel senior biotech analyst Stephen Willey, emphasizing the company’s focus on improving the therapeutic index of CTLA-4 inhibition

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Grupo Financiero Galicia Q1 Earnings Call Highlights

Grupo Financiero Galicia (NASDAQ:GGAL) management said profitability weakened sharply in the first quarter of 2026, as higher loan-loss provisions, limited loan demand and inflation accounting effects weighed on results, even as margins and efficiency showed sequential improvement. Pablo Firvida, h

AAP

Wall St ends lower as inflation worries push up yields

US stocks closed lower after yields climbed to their highest level in more than a year on mounting inflation concerns.

Barchart

Stocks Settle Lower on Rising Bond Yields

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -0.67%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -0.65%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.61%. June E-mini S&P futures (ESM26 ) fell -0.70%, and June E-mini Nasdaq futures...

AAP

How major US stock indexes fared Tuesday 5/19/2026

The U.S. stock market gave back more of its record-setting rally

The Economic Times

US stocks today: US stocks slip as inflation worries push Treasury yields higher

Wall Street closed lower as rising U.S. Treasury yields and persistent inflation fears pressured equities, with the Nasdaq leading losses. Elevated oil prices amid Iran tensions and uncertainty over Federal Reserve policy weighed on sentiment, while investors stayed cautious ahead of Nvidia earnings, seen as critical for sustaining AI-driven market…

MarketBeat

A Deep Dive Into NVIDIA’s Latest Portfolio Moves

NVIDIA's latest 13F filing does not tell the story it seems to at first glance. The apparent divergence in its CoreWeave and Nebius holdings is a prime example.

MarketBeat

Agios Pharmaceuticals Touts Strong AQVESME Launch as Sickle Cell Filing Advances

Agios Pharmaceuticals (NASDAQ:AGIO) executives said the company is focused on advancing mitapivat across rare hematologic diseases, highlighting early launch traction in thalassemia and a recently submitted supplemental new drug application for sickle cell disease during a presentation at the 2026 R

1 … 25 26 27 28

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Dow Jones Industrial Average

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.